What would be your choice of endocrine therapy for a patient with HR+ early stage second breast primary after completing 5 years of adjuvant AI?  

There are no studies to provide guidance in this situation as far as I am aware as most adjuvant studies excluded patients with prior history of breast cancer. Given that the second primary breast cancer was discovered 2 years after completion of adjuvant aromatase inhibitor, it probably developed a...